PRESS
Veterans
Administration Health Care System Purchases 15 Zargis Cardioscan Systems
July 30,
2010 (Stamford, CT): Zargis Medical Corp., a majority-owned subsidiary of
Speedus Corp. (OTCQB: SPDE), today announced that the VA Palo Alto Health Care
System (VAPAHCS), a northern California based hospital group that is part of
The Department of Veterans Affairs (VA) nationwide network of hospitals,
recently purchased 15 Zargis Cardioscan systems.
The VA
Palo Alto Health Care System (VAPAHCS) consists of three inpatient facilities
and seven outpatient clinics located in Palo Alto, California and the
surrounding region. Affiliated with the Stanford University School of Medicine,
VAPAHCS is also a teaching hospital, providing a full range of patient care
services with state-of-the-art technology as well as education and research.
VAPAHCS serves more than 85,000 enrolled veterans.
The Zargis
Cardioscan heart sound analysis software is designed to help healthcare
practitioners analyze cardiac sounds for the identification and classification
of suspected heart murmurs, which can be signs of heart disease. In conjunction
with the Web-enabled TeleStethTM platform, the system also allows healthcare
professionals to transmit physiological sounds to colleagues located anywhere
in the world.
"This
order represents the first acquisition of Zargis Cardioscan units by the
Veterans Administration," commented Zargis CEO John Kallassy. "We are
optimistic that this implementation at the VA Palo Alto Health Care System will
generate interest from other members of the VA's vast nationwide network of
healthcare facilities about incorporating Zargis Cardioscan into their patient
care."
The
mission of The Department of Veterans Affairs (VA) is to serve America's more
than 23-million Veterans and their families with dignity and compassion and to
be their principal advocate in ensuring that they receive medical care,
benefits, social support, and lasting memorials promoting the health, welfare,
and dignity of all Veterans in recognition of their service to this Nation. The
VA is the second largest Federal department. Services and benefits are provided
through a nationwide network of 153 hospitals, 956 outpatient clinics, 134
community living centers, 90 domiciliary residential rehabilitation treatment
programs, 232 Vet centers, 57 Veterans benefits regional offices, and 131
national cemeteries.
About Zargis
Medical Corp.
Zargis is
a global medical device company focused on improving health outcomes and
cost-effectiveness through diagnostic support software and innovation. Zargis
is majority-owned by Speedus Corp. (OTCQB: SPDE), and both 3M Company and Siemens
Corporate Research, a division of Siemens AG (NYSE:SI), hold equity positions.
For
additional information about Zargis or Speedus Corp., contact Peter Hodge at
888.773.3669 (ext. 23) or phodge@zargis.com, or visit the following Web sites:
www.zargis.com and www.speedus.com.
# # #
Statements
contained herein that are not historical facts, including but not limited to
statements about the Company's product, corporate identity and focus, may be
forward-looking statements that are subject to a variety of risks and
uncertainties. There are a number of important factors that could cause actual
results to differ materially from those expressed in any forward-looking
statements made by the Company, including, but not limited to, the continuing
development of the Company's sales, marketing and support efforts.
July 30, 2010
Veterans Administration Health Care System Purchases 15 Zargis Cardioscan Systems
July 21, 2010
Zargis Awarded U.S. Army Contract
June 11, 2010
Zargis to Launch FDA-Cleared Lung Sounds Analysis Technology from Stethographics, Inc. Exclusive License Agreement Allows Zargis to Expand into Respiratory Sounds Market
June 10, 2010
Zargis Medical Receives Top Honors at Medical Design Excellence Awards
May 27, 2010
Zargis Launches Telemedicine System with Real-Time Transmission of Stethoscope Sounds
May 13, 2010
U.S. Army to Showcase Zargis' Technology at Telemedicine Conference
April 20, 2010
3M Littmann Model 3200/Zargis Cardioscan Honored for Stethoscope/Software Design Innovation
April 12, 2010
Zargis Cardioscan Wins 'Best of the Best' red dot design award
September 29, 2009
Zargis Awarded Follow-On U.S. Army Contract; Mandates Expansion of Two Previous Awards
February 23, 2010
Zargis StethAssist & Zargis Cardioscan Cleared for Sale in Australia
February 15, 2010
Edison Best New Product Awards Taps 3M and Zargis
January 8th, 2010
Zargis Cardioscan Cleared for Sale in Canada
December 14, 2009
Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com
December 1, 2009 - IN THE NEWS
Popular Science Magazine Innovation of the Year Issue
December 1, 2009 - IN THE NEWS
Popular Science Cardioscan Video
December 1, 2009 - IN THE NEWS
Scoping Out Stethoscopes (Contemporary Pediatrics Magazine)
November 24, 2009
Zargis Cardioscan(TM) Featured on The Early Show on CBS
November 18, 2009 - IN THE NEWS
Zargis Builds a Better Stethoscope
November 12, 2009
3M Health Care and Zargis Medical Awarded "Innovation of the Year" for Littmann(R) Model 3200 Stethoscope with Cardioscan Software
October 21, 2009
Zargis Cleared as Apple iPhone Developer; Medical Applications for Smartphones Planned
September 24, 2009
3M Global Business Manager Ingrid Blair Joins Zargis Board
September 25, 2009 - IN THE NEWS
TAMC Heart Device Approved, Deploys to Pacific Areas
September 17, 2009
Zargis Receives FDA Clearance for Signal X6 Telemedicine Device; OK Allows Delivery to US Army
August 25, 2009
Zargis Cardioscan Unveiled Through Global Marketing and Distribution Alliance With 3M Company
August 19, 2009
3M Introduces First Electronic Stethoscope with Bluetooth Wireless Capability
October 9, 2008
Zargis Receives Additional Contracts from U.S. Army
February 20, 2008
Physicians use Cardioscan to Evaluate Student Athletes during Sports Physicals
October 25, 2007
3M and Zargis Announce Global Marketing Alliance
April 18, 2007
Zargis' Cardioscan Receives Televised News Coverage
November 6, 2006
Zargis Awarded U.S. Army Contract
October 9, 2006
Study Shows Cardioscan Leads to 41% Reduction of Unnecessary and Costly Cardiac Referrals by Physicians
September 13, 2006
Study Results for Zargis Cardioscan to be Presented at American Academy of Pediatrics Conference
September 11, 2006
The Wall Street Journal Recognizes Zargis Medical With Technology Innovation Award
November 16, 2005
Panel Agrees Zargis Prototype Would Improve Referral Accuracy with Heart Murmurs
October 26, 2005
Zargis Medical Awarded Fundamental New Patent
June 30, 2005
Zargis Conducts Physician Study to Show Potential Benefits to Physicians, Insurance Companies and Patients
March 15, 2005
Zargis CTO to Speak at Medical Devices Conference
November 29, 2004
White Paper "Computer Aided Auscultation of the Heart, the Clinical Opportunity" Available at Zargis Website
November 12, 2004
Zargis Signs Exclusive Pact With Johns Hopkins University
November 5, 2004
Zargis Medical Announces the Results of a Clinical Study in Hypertrophic Cardiomyopathy (HCM)
September 14, 2004
Zargis Medical receives FDA clearance: Energy Display and Timing Annotation Added to Cardioscan
June 1, 2004
FDA Clears Zargis' Pioneering Medical Device: First Computer-Aided Device to Assist in the Detection of Heart Murmurs
April 6, 2004
Zargis Medical Updates on FDA Submission
January 12, 2004
Healthcare Veteran Joins Zargis Board
October 27, 2003
Siemens Medical Solutions Leader Joins Zargis Board
July 9, 2003
Zargis Awarded Core Patent for Acoustic Cardioscan
May 21, 2003
Zargis Medical Files with FDA for Approval of Zargis Acoustic Cardioscan System
July 15, 2002
Zargis Medical Tests New Technology, Developed at Siemens, to Improve Diagnosis of Heart Murmurs
February 20, 2002
Zargis Medical Appoints Siemens' Veteran Hejazi As President And Chief Executive Officer
March 26, 2001
Siemens' and SPEEDUS' Start-Up, Zargis Medical Corp., Announces Four Appointments to Medical Experts Board; Changes Name From Sound Diagnostics
January 16, 2001
Siemens and SPEEDUS Team Together in Start-Up to Develop Technology For Rapidly Detecting Valvular Heart Disease During Routine Patient Examinations